Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON25426Active, not recruiting
Randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Ezetimibe with Placebo (2 arms). Primary endpoints: LDL-cholesterol efficacy and Safety of ezetimibe 10 mg. Started Aug 2006; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON25426.